
Why Is Your Baby Arching Their Back?
Babies arch their backs. Sometimes, this indicates pain, and other times, it's just a way for them to move. In some cases, an arched back, along with other symptoms, can signal a health condition.
If your baby arches their back without any other symptoms, chances are they're just a natural at yoga. Let your baby's pediatrician know about the back arching, just to be on the safe side.
Here's what to look for and what your baby might be trying to tell you.
What may cause a baby to arch their back?
There are many things that can cause a baby to arch their back, including discomfort, pain, or upset. Here are a few more common causes:
Gassiness
Gas can be a painful and common occurrence for babies. Your baby might arch their back when they have gas or an upset stomach.
This could be because arching the back stretches the stomach a bit and might make them feel a little better. You might notice that your baby arches their back after feeding, when trying to poop, and even while lying down.
Colic
Some babies experience bouts of fussiness that last for several days or weeks. This is sometimes labeled generically as colic.
Colic can start when your baby is only 4 to 6 weeks old and cause crying for hours at a time. Your baby may arch their back and cry out. Babies usually outgrow colic by the time they're 4 months old.
Baby reflux
Reflux, or gastroesophageal reflux, is common in babies right from birth to around 12 months to 18 months old.
Reflux happens in babies because the round muscles that pinch both ends of the stomach closed don't yet work properly in these new little humans. If your baby is premature, they might have more reflux.
A healthy baby can have reflux several times a day. But sometimes, if your baby is spitting up and seems to have other symptoms, they may also arch their back.
Similar to when babies have colic, they might arch their backs because it helps reduce the pain of reflux. You might notice this during and after feeding, while your baby is lying down, and even while they're fast asleep.
Body language
Sometimes your baby might arch their back because they don't want to be held or fed. This kind of body stiffening could be a sign to put them down or change their position.
Some babies have strong back muscles, and this may be the easiest way — other than crying — for their body to tell you what they want. Your little independent one may use the 'back arch method' to get out of unwanted cuddles up to the age of 2 years.
Startle reflex
Most babies have a startle reflex (also called the Moro reflex) when they hear a sudden or loud noise. It might also happen if they feel like they're falling or if they're moved suddenly.
Startling may cause a baby to suddenly straighten its legs forward and throw back its arms. The baby's head may also jerk backward, causing its back to arch. The startle reflex usually goes away by the time the baby is 2 to 4 months old.
Rollover attempts
As your little one gets used to tummy time, they're also building stronger back and neck muscles. They've learned to lift their head and realize that the more they can move, the more they can look around.
Your baby may arch their back during tummy time or while they're lying down on their side or back to get into a better position to explore. Some babies arch their backs when they're trying to roll over or move forward.
Temper tantrums
Some babies arch their backs and throw their heads back when they're upset or frustrated. This can happen while they're lying down, sitting down, standing, or even cradled in your arms. A baby in the heat of a tantrum may also cry, whine, and thrash about.
Many things might set off a tantrum. They may be hungry, finished feeding, want to go play, or frustrated because they can't express their needs to you. If your little one gets into the habit of this, look for warning signs like crying or being upset first, so you might be able to stop a tantrum in the early stages.
Seizure-like movements
Although it sounds serious, your baby may have seizure-like movements and behaviors that might be mistaken for seizures beginning in the first week of life. At this time, your baby's nervous system is still developing, so they may have uncoordinated or jerky movements. It can happen at any time, usually when your baby is awake or just drifting off to sleep.
Nerve injury during delivery
Though it's rare, a baby's delicate neck and back can get sprained or strained during a difficult delivery. Sometimes, the nerves between the neck and shoulders can be injured, which is called a brachial plexus injury.
This may cause back arching in your baby because they can move their back muscles and other strong muscles better than their neck muscles – especially if they are recovering from a birth injury.
Cerebral palsy
Cerebral palsy is a group of muscle control conditions. It usually happens when there is brain damage while your baby is still in the womb. About 1 in 345 children worldwide have a type of cerebral palsy.
Signs of this condition might show up while your little one is a baby or toddler. Signs include muscle floppiness, strong reflexes, and stiffening (like arching the back). Babies with cerebral palsy may also have trouble swallowing and moving their eyes. Some babies with this condition may also be more likely to have seizures.
Sandifer syndrome
Sandifer syndrome is a rare movement condition almost always associated with gastroesophageal reflux disease (GERD). It starts in babies or small children. Once the baby is treated for GERD (or it goes away on its own), this condition goes away.
Sandifer syndrome causes serious back arching in babies that can last for up to 3 minutes. It causes a frozen kind of back arching that can sometimes be mistaken for a baby seizure.
Back arching from this syndrome can happen about 10 times a day, usually after your baby has eaten. During back arching, your baby will also stretch their legs out backward and be very stiff. Other symptoms of Sandifer syndrome include:
tilting the head to one side
nodding head movements
poor feeding
vomiting
difficulties with eye movements
Is there a link between back arching and autism?
Children with autism spectrum disorder (ASD) typically show several signs. This sometimes includes repetitive motions like back arching, but remember that back arching is much more often due to other causes.
Autistic children may show symptoms around the time they are a year old (or earlier), but most kids aren't diagnosed until they're 3 to 4 years old.
A newborn or a baby that is only a few weeks to a few months old will likely not show signs of this condition. If your child is on the autism spectrum, they'll likely have several other signs along with back arching.
By the end of the first year, an autistic baby may show characteristic traits that are more common, like:
not smiling spontaneously at parents or caregivers
not using eye contact to communicate
not gesturing (waving or pointing) on their own
Later on, your child may show other repetitive motions, such as:
stiffening their arms
flapping their hands
walking on their toes
Solutions and treatments for back arching in babies
In most cases, your baby's back arching will go away on its own as they learn to roll over and control their body better, outgrow the startle reflex, and get more comfortable with people around them.
If there's a health problem that's making your little one arch their back, treating the underlying condition will solve the back arching. For example, treating common baby problems like gas and acid reflux will take care of the back arching.
For typical gasiness and baby reflux, you can try simple, low risk home remedies like:
holding or propping your baby upright after feeding
avoiding overfeeding
giving smaller feeds more often
using a smaller bottle and nipple size to stop air-gulping if this seems to be an issue
thickening breast milk or formula with a tiny bit of infant cereal (check with your pediatrician first, as this can have risks)
If your baby is throwing their head backward and arching their back in a toddler temper tantrum, gentle behavior training may help stop this. Teaching your child how to express themselves in a less dramatic way might help. Ask your pediatrician for recommendations.
When to call a doctor
Sometimes gassiness and fussiness can start to be accompanied by other symptoms that won't go away, and acid reflux might be a sign of a more serious health condition. Call your child's pediatrician urgently if your baby:
is crying for 3 hours or longer
is arching their back and showing other signs of pain
throws up every time you feed them
is irritable during feeding
refuses to feed
isn't gaining weight or has lost weight
isn't wetting their diaper
Look for symptoms of brain or nerve problems along with back arching. Contact your child's doctor or go to urgent or emergency care right away if your baby experiences:
sudden difficulty latching or feeding
weak sucking
difficulty swallowing
high-pitched cry
seizures
bulging or swollen soft spots on the head
stiffness
floppiness
strange head or neck posture
jerking movements
muscle spasms
»FIND CARE: Find a pediatrician in your area today.
The takeaway
If your baby's got back (arching), you probably don't have to worry. Babies arch their backs for many reasons — or for no reason at all. In a happy, comfortable, healthy baby, back arching likely has no cause and is just one of those things they do.
This common baby movement can also be a sign of other underlying health problems — sometimes serious. If you notice your baby arching their back, look for other symptoms. Let your pediatrician know what you notice. Make sure you take your new bundle of joy to all their regular check-ups.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
2 hours ago
- Yahoo
SIGA to Host Business Update Call on August 5, 2025 Following Release of Second-Quarter 2025 Results
NEW YORK, July 29, 2025 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (Nasdaq: SIGA), a commercial-stage pharmaceutical company, today announced that management will host a webcast and conference call to provide a business update at 4:30 P.M. ET on Tuesday, August 5, 2025. Participating in the call will be Diem Nguyen, Chief Executive Officer, and Daniel Luckshire, Chief Financial Officer. A live webcast of the call will also be available on the Company's website at in the Investor Relations section of the site, or by clicking here. Please log in approximately 5-10 minutes prior to the scheduled start time. Participants may access the call by dialing 1-800-717-1738 for domestic callers or 1-646-307-1865 for international callers. A replay of the call will be available for two weeks by dialing 1-844-512-2921 for domestic callers or 1-412-317-6671 for international callers and using Conference ID: 1130215. The archived webcast will be available in the Investor Relations section of the Company's website. About SIGA SIGA is a commercial-stage pharmaceutical company and leader in global health focused on the development of innovative medicines to treat and prevent infectious diseases. With a primary focus on orthopoxviruses, we are dedicated to protecting humanity against the world's most severe infectious diseases, including those that occur naturally, accidentally, or intentionally. Through partnerships with governments and public health agencies, we work to build a healthier and safer world by providing essential countermeasures against these global health threats. Our flagship product, TPOXX® (tecovirimat), is an antiviral medicine approved in the U.S. and Canada for the treatment of smallpox and authorized in Europe, the UK, and Japan for the treatment of smallpox, mpox (monkeypox), cowpox, and vaccinia complications. For more information about SIGA, visit Contacts:Suzanne Harnettsharnett@ and Investors Media Jennifer Drew-Bear, Edison GroupJdrew-bear@ Holly Stevens, CG Lifehstevens@
Yahoo
2 hours ago
- Yahoo
Sarepta shares rebound after shipments of gene therapy Elevidys resume in US
(Reuters) -Sarepta Therapeutics shares surged more than 30% before the bell on Tuesday, as analysts said the resumption of U.S. shipments for its muscular gene therapy partially removes financial headwinds and decreases the risk of market withdrawal. The company said on Monday it would resume shipments of Elevidys — approved in the U.S. to treat a rare condition called Duchenne muscular dystrophy — to patients who can walk. U.S. shipments to patients who cannot walk independently are still halted, following the death of two teenage boys earlier this year. These incidents brought heightened regulatory scrutiny to Sarepta in recent weeks, while the pause of shipments raised concerns about the future of Elevidys — the company's largest revenue generator. Sarepta's announcement followed the U.S. Food and Drug Administration's recommendation that the voluntary hold on shipments be removed after a probe showed the death of an 8-year-old boy in Brazil was not related to Elevidys. Wall Street analysts said the resumption of shipments would allow Sarepta to fulfill its near-term payments to partner Arrowhead and maintain access to its debt facilities. "The FDA's recommendation and the resumption of commercial treatment in the U.S. virtually eliminate the risk of Elevidys being formally withdrawn from the market," said William Blair analyst Sami Corwin. While the decision allows some patients to regain access to the treatment, analysts warned that patients and doctors could show hesitancy in light of the recent hit to reputation. "It remains to be seen how the news headlines regarding the patient deaths will affect commercial interest in the near term," Corwin said. Sarepta's partner Roche had also stopped Elevidys shipments in certain countries outside the U.S. Shares of Sarepta surged 36% to $18.85 in premarket trading. They have fallen more than 80% since the first Elevidys-related death was reported in March. Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data


New York Times
2 hours ago
- New York Times
UnitedHealth's Profits Fall as Costs of Care Continue to Rise
UnitedHealth Group, the giant health care conglomerate, said on Tuesday that it continued to struggle with higher-than-anticipated costs of providing medical care to patients enrolled in its health plans, reporting a drop in earnings for the quarter ended June 30. While UnitedHealth remained profitable, its operating earnings for the three months fell to $5.2 billion from $7.9 billion in the same period of 2024. Revenues, however, increased to $111.6 billion for the three months of 2025, compared with $98.9 billion for the same period of 2024. The higher costs were felt across the company's vast health insurance operations, including one of its most successful businesses, selling private Medicare plans as an alternative to traditional Medicare. UnitedHealth owns the nation's largest health insurer, UnitedHealthcare, which covers 50 million people. Other insurance companies have also reported rising medical costs and disappointing profits. Last Friday, Centene, a for-profit insurance company that focuses mostly on patients who are enrolled in Medicaid and Obamacare plans, was the latest insurer to blame rising expenses for poor financial results. But UnitedHealth's stumble, which began earlier this year, has shocked many of its investors who have come to rely on steady increases of profits from the conglomerate. Since November, the company's stock has lost roughly half of its value. The company owns an assortment of health care businesses, including surgery centers, a vast network of medical practices, and a big pharmacy benefit manager as well as health insurance plans. In the new earnings report, UnitedHealth acknowledged that many of the businesses housed under its Optum unit were also underperforming, including its network of physicians and other clinicians who provide care under the privatized portion of the Medicare program, known as Medicare Advantage. UnitedHealth has experienced a series of misfortunes over the last two years, including the murder of the chief executive of its insurance operations, Brian Thompson. Investors have lost confidence in the company's business model, and patients have grown increasingly frustrated with its methods. In May, it abruptly replaced its chief executive, Andrew Witty, with Stephen Hemsley, who had stepped down from the position in 2017. Last week, the company confirmed the Department of Justice was investigating its Medicare operations. UnitedHealth announced its earnings before the stock market opened. Mr. Hemsley took steps to reassure investors. The company, which had withdrawn its profit outlook for the year, provided investors with an estimate of what it expected to earn for 2025. It estimated revenues of slightly under $450 billion with net earnings of at least $14.65 per share. The company said it expected to return to earnings growth in 2026. 'UnitedHealth Group has embarked on a rigorous path back to being a high-performing company fully serving the health needs of individuals and society broadly,' Mr. Hemsley said in a statement in the company's earnings release. 'As we strengthen operating disciplines, positioning us for growth in 2026 and beyond, the people at UnitedHealth Group will continue to support the millions of patients, physicians and customers who rely on us, guided by a culture of service and longstanding values.'